BRIEF published on 09/10/2026 at 07:05, 2 days 6 hours ago Innate Pharma announces a conference on its half-year results Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
BRIEF published on 09/10/2026 at 07:05, 2 days 6 hours ago Innate Pharma fournira des informations financières lors de sa prochaine conférence téléphonique. Stratégie D'entreprise Conférence Téléphonique Mise À Jour Financière Innate Pharma Résultats 2026
BRIEF published on 09/10/2026 at 07:05, 2 days 6 hours ago Innate Pharma annonce une conférence sur ses résultats semestriels Résultats Financiers Immunothérapie Conférence Téléphonique Partenariats Biopharmaceutiques Innate Pharma
BRIEF published on 09/10/2026 at 07:05, 2 days 6 hours ago Innate Pharma to Provide Financial Insights in Upcoming Conference Call Conference Call Business Strategy Financial Update Innate Pharma 2026 Results
PRESS RELEASE published on 09/10/2026 at 07:00, 2 days 6 hours ago Informations privilégiées / Autres communiqués Innate Pharma organise une conférence téléphonique et un webcast le 17 septembre pour présenter ses résultats financiers et son activité au premier semestre 2026 Résultats Financiers Webcast Conférence Téléphonique Innate Pharma Immunothérapies
PRESS RELEASE published on 09/10/2026 at 07:00, 2 days 6 hours ago Inside Information / Other news releases Innate Pharma to host conference call on September 17, 2026, providing first half 2026 financial results and business update. Event details available on www.innate-pharma.com Financial Results Conference Call Biotechnology Business Update Innate Pharma
BRIEF published on 08/14/2026 at 11:35, 29 days 2 hours ago Innate Pharma annonce une conférence téléphonique et une webdiffusion à venir Biotechnologie Immunothérapie Webdiffusion Conférence Téléphonique Innate Pharma
BRIEF published on 08/14/2026 at 11:35, 29 days 2 hours ago Innate Pharma Announces Upcoming Conference Call and Webcast Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
PRESS RELEASE published on 08/14/2026 at 11:30, 29 days 2 hours ago Inside Information / Other news releases Innate Pharma to host conference call and webcast with key executives discussing latest updates. Event details available on company website Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
PRESS RELEASE published on 08/14/2026 at 11:30, 29 days 2 hours ago Informations privilégiées / Autres communiqués Innate Pharma organise une conférence téléphonique et un webcast le 14 août 2026 à 14h00 CEST / 8h00 EDT. Détails sur www.innate-pharma.com Biotechnologie Webcast Conférence Téléphonique Innate Pharma Immunothérapies
Published on 09/12/2026 at 02:35, 11 hours 6 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 41 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 36 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 16 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 41 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 11 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 26 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 31 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 56 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 26 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
